Robert S Wallis. Show Affiliations »
Abstract
Entities: Chemical Disease
Mesh: See more » Antibodies, Monoclonal/therapeutic useAntirheumatic Agents/therapeutic useAntitubercular Agents/therapeutic useHumansImmunotherapy/methodsInfliximabRecurrenceTuberculosis/drug therapyTuberculosis/immunologyTumor Necrosis Factor-alpha/antagonists & inhibitorsTumor Necrosis Factor-alpha/immunology
Substances: See more » Antibodies, MonoclonalAntirheumatic AgentsAntitubercular AgentsTumor Necrosis Factor-alphaInfliximab
Year: 2005 PMID: 16039841 DOI: 10.1016/j.rmed.2005.06.010
Source DB: PubMed Journal: Respir Med ISSN: 0954-6111 Impact factor: 3.415